Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 1;10(2):45-60.
doi: 10.1089/caff.2019.0022. Epub 2020 Jun 4.

Role of Adenosine in Epilepsy and Seizures

Affiliations
Review

Role of Adenosine in Epilepsy and Seizures

Fabio C Tescarollo et al. J Caffeine Adenosine Res. .

Abstract

Adenosine is an endogenous anticonvulsant and neuroprotectant of the brain. Seizure activity produces large quantities of adenosine, and it is this seizure-induced adenosine surge that normally stops a seizure. However, within the context of epilepsy, adenosine plays a wide spectrum of different roles. It not only controls seizures (ictogenesis), but also plays a major role in processes that turn a normal brain into an epileptic brain (epileptogenesis). It is involved in the control of abnormal synaptic plasticity and neurodegeneration and plays a major role in the expression of comorbid symptoms and complications of epilepsy, such as sudden unexpected death in epilepsy (SUDEP). Given the important role of adenosine in epilepsy, therapeutic strategies are in development with the goal to utilize adenosine augmentation not only for the suppression of seizures but also for disease modification and epilepsy prevention, as well as strategies to block adenosine A2A receptor overfunction associated with neurodegeneration. This review provides a comprehensive overview of the role of adenosine in epilepsy.

Keywords: adenosine; adenosine kinase; adenosine receptors; epilepsy; epileptogenesis; seizure.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

References

    1. White HS, Smith MD, Wilcox KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol. 2007;81:85–110 - PubMed
    1. Pitkanen A, Nehlig A, Brooks-Kayal AR, et al. . Issues related to development of antiepileptogenic therapies. Epilepsia. 2013;54(Suppl 4):35–43 - PMC - PubMed
    1. Loscher W, Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia. 2011;52:657–678 - PubMed
    1. Boison D. The biochemistry and epigenetics of epilepsy: focus on adenosine and glycine. Front Mol Neurosci. 2016;9:26. - PMC - PubMed
    1. Boison D, Steinhauser C. Epilepsy and astrocyte energy metabolism. Glia. 2018;66:1235–1243 - PMC - PubMed

LinkOut - more resources